Director Carolyn K. Pittman filed a Form 4 with the SEC on September 9, 2026, reporting the acquisition of phantom stock units in Minerals Technologies Inc. (NYSE:MTX) dated September 4, 2026.
Sheri Lewis, Executive Vice President of Global Operations at Merit Medical Systems Inc., filed a Form 4 on September 9, 2026, disclosing the receipt of 8,371 restricted stock units on September 4, 2026.
Director Florian Schonharting filed a Form 4 with the SEC on September 9, 2026, disclosing the acquisition of share options in GH Research PLC on September 8, 2026.
Chris Schenk, President and Chief Underwriting Officer of Ategrity Specialty Insurance Co Holdings, filed a Form 4 on September 9, 2026, reporting the acquisition of stock options on September 4, 2026.
Procore Technologies, Inc. filed a Form 8-K on September 9, 2026, reporting the completion of its previously announced acquisition of DroneDeploy, Inc. for approximately $845.0 million in cash.
FS Credit Opportunities Corp. filed an 8-K on September 9, 2026, disclosing that its reconvened Annual Meeting of Stockholders was adjourned a second time due to the absence of a preferred stockholder quorum, with the meeting now scheduled to reconvene on September 24, 2026.
Joby Aviation, Inc. filed a current report on September 9, 2026, disclosing that its Board of Directors appointed Sergey Novikov as the company's Principal Accounting Officer, effective September 2, 2026.
Wealthfront Corporation filed a Form 8-K with the SEC on September 9, 2026, announcing the release of its financial results for the second fiscal quarter ended July 31, 2026, and disclosing a supplemental information presentation posted to its investor relations website.
Brent Pfeiffenberger, President and Chief Executive Officer of Century Therapeutics, Inc. (NASDAQ:IPSC), reported a change in beneficial ownership of common stock on September 9, 2026, stemming from a transaction dated September 4, 2026.
Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics, Inc., filed a Form 4 on September 9, 2026, reporting the sale of 534 shares of common stock on September 8, 2026, to cover tax withholding obligations tied to the vesting of restricted stock …